GO:0016070 | RNA metabolic process | 5.44% (8/147) | 2.95 | 1e-05 | 0.001028 |
GO:0140098 | catalytic activity, acting on RNA | 4.08% (6/147) | 3.7 | 7e-06 | 0.001074 |
GO:0090304 | nucleic acid metabolic process | 5.44% (8/147) | 2.64 | 4.5e-05 | 0.001571 |
GO:0006520 | cellular amino acid metabolic process | 3.4% (5/147) | 3.71 | 4e-05 | 0.001573 |
GO:0033036 | macromolecule localization | 3.4% (5/147) | 3.42 | 0.000107 | 0.00159 |
GO:0008104 | protein localization | 3.4% (5/147) | 3.42 | 0.000107 | 0.00159 |
GO:0034641 | cellular nitrogen compound metabolic process | 6.8% (10/147) | 2.25 | 5.1e-05 | 0.001606 |
GO:1901360 | organic cyclic compound metabolic process | 6.8% (10/147) | 2.34 | 3.2e-05 | 0.001639 |
GO:0006886 | intracellular protein transport | 3.4% (5/147) | 3.73 | 3.7e-05 | 0.001652 |
GO:0006725 | cellular aromatic compound metabolic process | 6.8% (10/147) | 2.4 | 2.2e-05 | 0.001686 |
GO:0006082 | organic acid metabolic process | 4.08% (6/147) | 3.01 | 0.000105 | 0.001728 |
GO:0043436 | oxoacid metabolic process | 4.08% (6/147) | 3.02 | 0.0001 | 0.001736 |
GO:0046483 | heterocycle metabolic process | 6.8% (10/147) | 2.35 | 2.9e-05 | 0.001806 |
GO:0051641 | cellular localization | 4.08% (6/147) | 3.74 | 6e-06 | 0.001813 |
GO:0015833 | peptide transport | 3.4% (5/147) | 3.44 | 0.0001 | 0.001835 |
GO:0015031 | protein transport | 3.4% (5/147) | 3.44 | 0.0001 | 0.001835 |
GO:0042886 | amide transport | 3.4% (5/147) | 3.44 | 0.0001 | 0.001835 |
GO:0045184 | establishment of protein localization | 3.4% (5/147) | 3.44 | 0.0001 | 0.001835 |
GO:0009987 | cellular process | 14.97% (22/147) | 1.24 | 0.000143 | 0.001945 |
GO:0044281 | small molecule metabolic process | 4.76% (7/147) | 2.64 | 0.000138 | 0.001959 |
GO:0046907 | intracellular transport | 3.4% (5/147) | 3.54 | 7e-05 | 0.001988 |
GO:0051649 | establishment of localization in cell | 3.4% (5/147) | 3.5 | 8.1e-05 | 0.002108 |
GO:0019752 | carboxylic acid metabolic process | 4.08% (6/147) | 3.03 | 9.5e-05 | 0.002287 |
GO:0071705 | nitrogen compound transport | 3.4% (5/147) | 3.26 | 0.000178 | 0.002308 |
GO:0071702 | organic substance transport | 3.4% (5/147) | 3.19 | 0.000224 | 0.002795 |
GO:0006396 | RNA processing | 2.72% (4/147) | 3.54 | 0.000385 | 0.004446 |
GO:0006139 | nucleobase-containing compound metabolic process | 5.44% (8/147) | 2.2 | 0.000377 | 0.004522 |
GO:0005488 | binding | 21.77% (32/147) | 0.88 | 0.000411 | 0.004585 |
GO:0044283 | small molecule biosynthetic process | 2.72% (4/147) | 3.29 | 0.000753 | 0.007835 |
GO:0034660 | ncRNA metabolic process | 2.72% (4/147) | 3.29 | 0.000753 | 0.007835 |
GO:0022402 | cell cycle process | 1.36% (2/147) | 5.24 | 0.001179 | 0.010819 |
GO:0007010 | cytoskeleton organization | 1.36% (2/147) | 5.24 | 0.001179 | 0.010819 |
GO:1990234 | transferase complex | 1.36% (2/147) | 5.24 | 0.001179 | 0.010819 |
GO:0008652 | cellular amino acid biosynthetic process | 1.36% (2/147) | 5.24 | 0.001179 | 0.010819 |
GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters | 1.36% (2/147) | 4.66 | 0.002731 | 0.021304 |
GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.36% (2/147) | 4.66 | 0.002731 | 0.021304 |
GO:0016072 | rRNA metabolic process | 1.36% (2/147) | 4.66 | 0.002731 | 0.021304 |
GO:0006364 | rRNA processing | 1.36% (2/147) | 4.66 | 0.002731 | 0.021304 |
GO:0044424 | intracellular part | 4.76% (7/147) | 1.9 | 0.002838 | 0.021595 |
GO:0009396 | folic acid-containing compound biosynthetic process | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0071173 | spindle assembly checkpoint | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0031414 | N-terminal protein acetyltransferase complex | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0071174 | mitotic spindle checkpoint | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0009081 | branched-chain amino acid metabolic process | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:1901987 | regulation of cell cycle phase transition | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:1901988 | negative regulation of cell cycle phase transition | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0007093 | mitotic cell cycle checkpoint | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0033044 | regulation of chromosome organization | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:2001251 | negative regulation of chromosome organization | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0009082 | branched-chain amino acid biosynthetic process | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:1905819 | negative regulation of chromosome separation | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:1905818 | regulation of chromosome separation | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0051985 | negative regulation of chromosome segregation | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0042559 | pteridine-containing compound biosynthetic process | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0046653 | tetrahydrofolate metabolic process | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0006760 | folic acid-containing compound metabolic process | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0031577 | spindle checkpoint | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0033045 | regulation of sister chromatid segregation | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0033046 | negative regulation of sister chromatid segregation | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0045839 | negative regulation of mitotic nuclear division | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0045930 | negative regulation of mitotic cell cycle | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0051783 | regulation of nuclear division | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0010965 | regulation of mitotic sister chromatid separation | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0009235 | cobalamin metabolic process | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0046654 | tetrahydrofolate biosynthetic process | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0051983 | regulation of chromosome segregation | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0031417 | NatC complex | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0007088 | regulation of mitotic nuclear division | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0051784 | negative regulation of nuclear division | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0007094 | mitotic spindle assembly checkpoint | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0010948 | negative regulation of cell cycle process | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:0009236 | cobalamin biosynthetic process | 0.68% (1/147) | 7.24 | 0.006596 | 0.02237 |
GO:1901363 | heterocyclic compound binding | 10.2% (15/147) | 1.18 | 0.002633 | 0.022822 |
GO:0097159 | organic cyclic compound binding | 10.2% (15/147) | 1.18 | 0.002633 | 0.022822 |
GO:0008150 | biological_process | 22.45% (33/147) | 0.62 | 0.006829 | 0.022909 |
GO:0004540 | ribonuclease activity | 1.36% (2/147) | 4.54 | 0.003214 | 0.02332 |
GO:0004521 | endoribonuclease activity | 1.36% (2/147) | 4.54 | 0.003214 | 0.02332 |
GO:0044237 | cellular metabolic process | 10.2% (15/147) | 1.01 | 0.007681 | 0.024706 |
GO:0009058 | biosynthetic process | 4.08% (6/147) | 1.81 | 0.007675 | 0.024944 |
GO:0004519 | endonuclease activity | 1.36% (2/147) | 3.92 | 0.007596 | 0.024947 |
GO:0034470 | ncRNA processing | 1.36% (2/147) | 3.92 | 0.007596 | 0.024947 |
GO:0140101 | catalytic activity, acting on a tRNA | 1.36% (2/147) | 4.44 | 0.003733 | 0.025323 |
GO:0016053 | organic acid biosynthetic process | 2.04% (3/147) | 3.27 | 0.003687 | 0.025566 |
GO:0046394 | carboxylic acid biosynthetic process | 2.04% (3/147) | 3.27 | 0.003687 | 0.025566 |
GO:0006807 | nitrogen compound metabolic process | 11.56% (17/147) | 1.03 | 0.003983 | 0.026439 |
GO:0004386 | helicase activity | 1.36% (2/147) | 4.34 | 0.004289 | 0.02788 |
GO:0006996 | organelle organization | 1.36% (2/147) | 3.78 | 0.009156 | 0.029149 |
GO:0003674 | molecular_function | 32.65% (48/147) | 0.45 | 0.009332 | 0.029411 |
GO:1901566 | organonitrogen compound biosynthetic process | 2.72% (4/147) | 2.57 | 0.004685 | 0.029831 |
GO:0140097 | catalytic activity, acting on DNA | 1.36% (2/147) | 3.72 | 0.009985 | 0.031152 |
GO:0008270 | zinc ion binding | 3.4% (5/147) | 1.94 | 0.010186 | 0.031465 |
GO:0043167 | ion binding | 8.16% (12/147) | 1.1 | 0.010555 | 0.032286 |
GO:0044464 | cell part | 5.44% (8/147) | 1.6 | 0.005226 | 0.03261 |
GO:0140029 | exocytic process | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0048278 | vesicle docking | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0022406 | membrane docking | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0006904 | vesicle docking involved in exocytosis | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0006553 | lysine metabolic process | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0009066 | aspartate family amino acid metabolic process | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0009067 | aspartate family amino acid biosynthetic process | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0009085 | lysine biosynthetic process | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0009089 | lysine biosynthetic process via diaminopimelate | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0000278 | mitotic cell cycle | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0046451 | diaminopimelate metabolic process | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0042558 | pteridine-containing compound metabolic process | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0051640 | organelle localization | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0005680 | anaphase-promoting complex | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0043648 | dicarboxylic acid metabolic process | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0140056 | organelle localization by membrane tethering | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0000151 | ubiquitin ligase complex | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0000152 | nuclear ubiquitin ligase complex | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 0.68% (1/147) | 6.24 | 0.013149 | 0.033628 |
GO:0016071 | mRNA metabolic process | 1.36% (2/147) | 3.49 | 0.013616 | 0.034539 |
GO:0006397 | mRNA processing | 1.36% (2/147) | 3.54 | 0.012662 | 0.038355 |
GO:0071704 | organic substance metabolic process | 11.56% (17/147) | 0.81 | 0.016525 | 0.041579 |
GO:0004518 | nuclease activity | 1.36% (2/147) | 3.29 | 0.017732 | 0.043562 |
GO:0046914 | transition metal ion binding | 3.4% (5/147) | 1.74 | 0.017477 | 0.043622 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4.76% (7/147) | 1.4 | 0.0177 | 0.043829 |
GO:0031248 | protein acetyltransferase complex | 0.68% (1/147) | 5.66 | 0.01966 | 0.044772 |
GO:0007346 | regulation of mitotic cell cycle | 0.68% (1/147) | 5.66 | 0.01966 | 0.044772 |
GO:0051129 | negative regulation of cellular component organization | 0.68% (1/147) | 5.66 | 0.01966 | 0.044772 |
GO:0033043 | regulation of organelle organization | 0.68% (1/147) | 5.66 | 0.01966 | 0.044772 |
GO:0010639 | negative regulation of organelle organization | 0.68% (1/147) | 5.66 | 0.01966 | 0.044772 |
GO:0010564 | regulation of cell cycle process | 0.68% (1/147) | 5.66 | 0.01966 | 0.044772 |
GO:0002161 | aminoacyl-tRNA editing activity | 0.68% (1/147) | 5.66 | 0.01966 | 0.044772 |
GO:1903047 | mitotic cell cycle process | 0.68% (1/147) | 5.66 | 0.01966 | 0.044772 |
GO:1902493 | acetyltransferase complex | 0.68% (1/147) | 5.66 | 0.01966 | 0.044772 |
GO:0003676 | nucleic acid binding | 5.44% (8/147) | 1.27 | 0.018853 | 0.045953 |
GO:0043229 | intracellular organelle | 2.04% (3/147) | 2.37 | 0.020526 | 0.046408 |
GO:0043226 | organelle | 2.04% (3/147) | 2.32 | 0.022404 | 0.049929 |